Science
SSTI is focused on the discovery and development of novel drugs that target molecules and cellular processes fundamental to cancer. Our drug targets include those in the Wnt, Notch, and Myc signaling pathways. We have already identified potent modulators of these pathways, and have patent protection on multiple lead compounds. These breakthrough technologies include:
